Phase I and II clinical trials conducted have shown improved cognitive and motor function with different drugs from GLP-1RA group although the small sized and limited duration of trials have not provided a conclusive result to influence the practice, although with further advancement in ongoing trials effects observed may be noteworthy for intervention in future practice (119)
Advertencias "NO RECOMENDABLE PARA MENORES DE 15 AOS, EN EMBARAZO NI LACTANCIA" Mantener en un lugar fresco, seco, fuera del alcance de los nios y alejado de la luz y el calor (15-25C)
Either way can lead to weight reduction, but the mechanisms of action are distinct
At 24 h after BSO treatment, HepG2 cells were exposed to 50 M AQ-QI or 30 M DEAQ-QI in DMEM medium without FBS for 2.5 h
The daily dose will depend, according to the judgement of the primary care physician, on the patient's weight, age and condition